Angelica gigas extract emerges as a potential treatment for vascular disease

A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science) Volume 15, Issue 23, entitled, “Angelica gigas extract inhibits acetylation of eNOS via IRE1α sulfonation/RIDD-SIRT1-mediated posttranslational modification in vascular dysfunction.”

The Physician Who Cured Himself

“The Doctor’s Art” is a weekly podcast that explores what makes medicine meaningful, featuring profiles and stories from clinicians, patients, educators, leaders, and others working

August 2, 2023

Merck’s KEYTRUDA regimen gets positive EMA CHMP opinion

Share this article Merck’s Keytruda received approval in the US in October 2023. Credit: Atmosphere1 / Shutterstock.com. Merck (MSD)’s anti-programmed death receptor-1 (PD-1) therapy Keytruda

February 26, 2024

Gut microbiota imbalance linked to higher UTI risks in women

Study reveals that gut microbial dysbiosis and frequent antibiotic use are key risk factors for recurrent urinary tract infections (UTIs) in women, emphasizing the importance

June 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.